TP53 and colorectal carcinoma: This study assessed the expression levels of candidates (squalene epoxidase: SQLE, p53 wild type: p53WT, p53 mutant: p53MT, and GSK3β activity inhibition measured by phosphorylation at serine 9 of GSK3β:GSK3βpS9) according to patients' age and CRC aggressiveness.